Navigation Links
Cepheid Reports 2009 Second Quarter Results
Date:7/30/2009

SUNNYVALE, Calif., July 30 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today reported revenue for the second quarter of 2009 of $41.0 million. Net loss was $6.8 million, or $(0.12) per share, which compares to revenue of $42.1 million and a net loss of $7.7 million, or $(0.13) per share, in the second quarter of 2008.

Excluding amortization of purchased intangible assets, stock compensation and restructuring expenses, non-GAAP net loss for the second quarter was $2.2 million, or $(0.04) per share. This compares to a non-GAAP net loss of $3.7 million, or $(0.06) per share, in the second quarter of 2008.

"Our Clinical reagent business demonstrated strong growth as expected, highlighting continued adoption of the GeneXpert System's expanding test menu which now includes six FDA-cleared products in the US and eleven CE-marked products outside the US," said John Bishop, Cepheid's Chief Executive Officer. "Despite the ongoing challenges in the broader economy, 105 GeneXpert Systems were placed during the second quarter, reflecting the unique aspects of the system in ease of use, accuracy of test results and efficient management of scarce and costly healthcare resources."

Operational Overview

  • Total product sales of $39.6 million in the second quarter of 2009 compared to $39.0 million in the second quarter of 2008. By industry, product sales were, in millions:

                                            Three Months Ended June 30,
                                          2009          2008         Change
                                          ----          ----         ------
           Clinical Systems               $5.7          $6.6           -14%
           Clinical Reagents              2
'/>"/>
SOURCE Cepheid
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference
2. Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results
3. Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
4. Cepheid to Present at the Needham Tenth Annual Growth Stock Conference
5. Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association
6. Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing
7. Cepheid Reports Record Revenue of $44.8 Million
8. Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations
9. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
10. Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections
11. Cepheid Reports Fourth Quarter and Full Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... option for patients with Type V AC joint injuries, ... The study, presented today at the American Orthopaedic Society ... military personnel returned to duty faster when surgery was ... 24 patients, with 7 receiving surgical treatment and 17 ...
(Date:3/28/2015)... 28, 2015 Aureus Medical Group ... including physical therapy jobs, has announced that it ... Physical Therapy Association Annual Conference to be held ... Hotel in Columbus, OH. , The OPTA ... exhibits with products and services. , Representatives ...
(Date:3/28/2015)... 2015 ARDX will sponsor the 7th Annual ... at the Chesapeake Conference Center in Chesapeake, Virginia. Each ... event for women in the Hampton Roads region. The ... Women’s Lives. Women grow stronger through sharing their stories ... This year the WWC™ theme is T-talk where we will ...
(Date:3/27/2015)... 2015 The Monogamy Method ... Samantha Sanderson and Jason Rogers has just been released ... attention. The commotion surrounding the course's launch has caught ... publish an in-depth review of the new program. , ... in their lives suddenly start pulling away or expressing ...
(Date:3/27/2015)... 27, 2015 The federal court overseeing ... the statin medication increases the risk that a patient ... Motion to Dismiss four individual cases that had been ... Order issued in the U.S. District Court, District of ... the dismissals were warranted because the plaintiffs in those ...
Breaking Medicine News(10 mins):Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
... May 27 The Food Allergy &,Anaphylaxis Network (FAAN) ... N.Y., on May 31, 2008. Many families struggle with,how ... attendees have,been living with food allergies for years or ... Conference attendees will learn tips and strategies for ...
... closer to that of roses or bananas? Weizmann Institute scientists ... first time that smells can be mapped and the relative ... in Nature Methods, may help scientists to unravel the basic ... enabling odors to be digitized and transferred via computer in ...
... Please join the Urban League of,Philadelphia for FREE Open ... and teens, ages 19 and under, in,Pennsylvania,s Children,s Health Insurance ... office of the Urban League of Philadelphia, 121,S. Broad Street ... building on:, Wednesday, May 28th, 6pm - 8pm ...
... current recommended daily allowance (RDA) of vitamin D for ... reveals that children may need and can safely take ... in The Endocrine Societys Journal of Clinical Endocrinology & ... health of children worldwide and may have other long-term ...
... China, May 27 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International ... developer, manufacturer,and marketer of medical devices worldwide, ... and co-chief executive officer, Mr. Minghe,Cheng, Mindray,s ... Ms.,May Li, Mindray,s investor relations manager, will ...
... May 27, 2008 Three researchers who ... as part of the institutions acclaimed Endowed Scholars ... biomedical scientists nationwide who today were named Howard ... assistant professor of immunology, Dr. Youxing Jiang, assistant ...
Cached Medicine News:Health News:FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in New York 2Health News:FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in New York 3Health News:Weizmann Institute scientists produce the first smell map 2Health News:Does Your Child Have Health Insurance? Urban League of Philadelphia Announces Free Open Houses for CHIP Enrollment 2Health News:Current vitamin D recommendations fraction of safe, perhaps essential levels for children 2Health News:Mindray to Attend Goldman Sachs 29th Annual Global Healthcare Conference 2Health News:UT Southwestern faculty members named Howard Hughes investigators 2Health News:UT Southwestern faculty members named Howard Hughes investigators 3Health News:UT Southwestern faculty members named Howard Hughes investigators 4
(Date:3/27/2015)... 2015   Hospira, Inc. (NYSE: ... the world,s leading provider of injectable drugs and ... evaluation of biosimilarity of its proposed biosimilar, Epoetin ... (FDA) conditionally approved name of RETACRIT™, compared to ... study data were presented at the National Kidney ...
(Date:3/27/2015)... 27, 2015 Concord Medical Services Holdings ... CCM ), a leading specialty hospital management solution ... radiotherapy and diagnostic imaging centers in ... a purchase agreement under which Concord Medical Services ... the Company, agreed to acquire the Fortis Surgical ...
(Date:3/26/2015)... , March 26, 2015 "Whether it,s our ... one day." In a single sentence, ... scientific officer at Pfizer,s Centers for Therapeutic Innovation ... scientists fueling progress at America,s biopharmaceutical companies. ... side-by-side with academia, patient foundations and the National Institutes ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L)....
Intended for the quantitative determination of glucose in serum. Reaction: endpoint. Wavelength: 500 nm. Linearity: 500 mg/dL (27.8 mmol/L)....
For the quantitative determination of Glucose in serum. Endpoint Reaction Product measured at 520 nm. Linearity: 500 mg/dl....
For the quantitative determination of Glucose in serum. Endpoint reaction (NAD -> NADH) measured at 340 nm. Linearity: 600 mg/dl. Liquid working reagent prepared with simple 1:9 dilution....
Medicine Products: